Pacira | PCRX - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Astellas Pharma JPY 4.56T 770.92B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Cara Therapeutics USD 366M 338M 2025-09
Coherus Biosciences USD 172M 19M 2025-12
Heron Therapeutics USD 238M 7M 2025-12
J&J USD 579.15B 78.91B 2026-03
Ligand Pharmaceuticals USD 3.98B 241M 2026-03
Nektar Therapeutics USD 11.91B 11.05B 2026-06
Novo Nordisk A/S DKK 1.03T 421.31B 2026-03
Pacira USD 915M 149M 2026-03
Perrigo USD 1.31B 604M 2026-03
Pfizer USD 153.81B 12.24B 2026-03
Supernus Pharmaceuticals USD 2.98B 126M 2026-03
Teva Pharmaceutical Industries USD 34.27B 2.14B 2026-03
Zoetis USD 49.71B 5.74B 2026-03